Unsupervised Clustering Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Systemic sclerosis (SSc) is a heterogeneous systemic autoimmune disease with distinct prognosis according to patients. Interstitial lung disease (ILD) concerns almost 50 % of SSc patients and represents the main cause of mortality. SSc-ILD is variable: from limited forms (with asymptomatic patients) to extensive lesions. Disease course in SSc-ILD is also highly variable: patients can experience stable disease, slow or fast progression. Investigators performed unsupervised clustering analysis to classify SSc-ILD according to elementary radiological lesions on HRCT scan.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with systemic sclerosis according to 2013 ACR/EULAR criteria

• Patients with interstitial lung disease on HRCT chest

Locations
Other Locations
France
Central Hospital
RECRUITING
Nancy
Contact Information
Primary
Paul DECKER, MD
p.decker@chru-nancy.fr
+33383157240
Time Frame
Start Date: 2023-01-01
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 100
Treatments
SSc-ILD patients
Sponsors
Leads: Central Hospital, Nancy, France

This content was sourced from clinicaltrials.gov

Similar Clinical Trials